West Pharmaceutical Services (WST) : Kings Point Capital Management scooped up 135 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 12, 2016. The investment management firm now holds a total of 108,365 shares of West Pharmaceutical Services which is valued at $7.8 Million.West Pharmaceutical Services makes up approximately 1.99% of Kings Point Capital Management’s portfolio.
Other Hedge Funds, Including , Ameritas Investment Partners boosted its stake in WST in the latest quarter, The investment management firm added 154 additional shares and now holds a total of 16,507 shares of West Pharmaceutical Services which is valued at $1.2 Million. West Pharmaceutical Services makes up approx 0.08% of Ameritas Investment Partners’s portfolio.Blackrock Group Ltd boosted its stake in WST in the latest quarter, The investment management firm added 9,045 additional shares and now holds a total of 49,771 shares of West Pharmaceutical Services which is valued at $3.6 Million. Eos Focused Equity Management sold out all of its stake in WST during the most recent quarter. The investment firm sold 49,830 shares of WST which is valued $3.6 Million.Johnson Financial Group reduced its stake in WST by selling 295 shares or 52.87% in the most recent quarter. The Hedge Fund company now holds 263 shares of WST which is valued at $18,847.Los Angeles Capital Management Equity Research Inc reduced its stake in WST by selling 840 shares or 3.07% in the most recent quarter. The Hedge Fund company now holds 26,518 shares of WST which is valued at $1.9 Million. West Pharmaceutical Services makes up approx 0.02% of Los Angeles Capital Management Equity Research Inc’s portfolio.
West Pharmaceutical Services opened for trading at $71.63 and hit $72.8 on the upside on Friday, eventually ending the session at $72.73, with a gain of 2.06% or 1.47 points. The heightened volatility saw the trading volume jump to 5,90,052 shares. Company has a market cap of $5,315 M.
On the company’s financial health, West Pharmaceutical Services reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.51. The company had revenue of $362.10 million for the quarter, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.
Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).